Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZLAB · against 1,216 other Healthcare companies
Ranked #433 of 1,217 · scores higher than 64% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 60–69, including ZLAB · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, which is stronger than most Healthcare peers.
| Metric | ZLAB | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 5.1% | 6.1% | 47% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 21.3% | 5.8% | 82% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 433 | 2.7B CAD (≈$2.0B) | 64 | 54 | |
| 433 | 4.0B USD | 64 | 46 | |
| 433 | 255M USD | 64 | 36 | |
| 433 | 142.9B INR (≈$1.7B) | 64 | 64 | |
| 433 | 2.5B USD | 64 | 31 | |
| 445 | 2.9B HKD (≈$365M) | 63 | 84 | |
| 445 | 19.0B CNY (≈$2.7B) | 63 | 55 | |
| 445 | 10.8B SAR (≈$2.9B) | 63 | 68 | |
| 445 | 10.8B CNY (≈$1.5B) | 63 | 80 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score